AIM
ABMD

Achmea Investment Management’s Abiomed Inc ABMD Stock Holding History

Achmea Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,692
Closed -$661K – 663
2022
Q3 		$661K Buy
+2,692
New +$727K 0.02% 451
2022
Q2 		– Sell
-2,692
Closed -$891K – 665
2022
Q1 		$891K Hold
2,692
– – 0.02% 467
2021
Q4 		$967K Buy
+2,692
New +$910K 0.05% 252
2020
Q1 		– Sell
-6,671
Closed -$1.14M – 585
2019
Q4 		$1.14M Hold
6,671
– – 0.04% 344
2019
Q3 		$1.19M Hold
6,671
– – 0.05% 335
2019
Q2 		$1.74M Hold
6,671
– – 0.07% 293
2019
Q1 		$1.91M Hold
6,671
– – 0.08% 250
2018
Q4 		$2.17M Hold
6,671
– – 0.1% 215
2018
Q3 		$3M Hold
6,671
– – 0.11% 211
2018
Q2 		$2.73M Buy
+6,671
New +$2.42M 0.1% 242

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Achmea Investment Management's ABMD Position: Q4 2022 in Review

Achmea Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,692 shares — an estimated $661K sold.

Achmea Investment Management first reported a position in ABMD in Q2 2018 and held it in 10 quarters. The position peaked at $3M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Achmea Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Achmea Investment Management sold 2,692 Abiomed Inc shares in Q4 2022, an estimated $661K.
  • Achmea Investment Management first reported a position in Abiomed Inc in Q2 2018 and held it in 10 quarters.
  • Achmea Investment Management's Abiomed Inc position peaked at $3M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Achmea Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.